openalexBiomedical Chromatography2021-02-11Cited by 15
Metabolite profiling of IMID‐2, a novel anticancer molecule of piperazine derivative: <i>In silico</i> prediction, <i>in vitro</i> and <i>in vivo</i> metabolite characterization using UPLC–QTOF–MS/MS
Niraj Kumar Panday, Disha Thakkar, Sagarkumar Patel, Amit Shard, Pinaki Sengupta
IMID-2, a newly identified piperazine-based anticancer molecule, has been shown to be cytotoxic against various cancer cell lines. The primary aim of this research was to identify and characterize possible metabolites of the molecule formed during biotransformation. A metabolite…
Also available via: Wiley